ABSTRACT
S
ingle parathyroid adenoma (PTA) is the most common cause of primary hyperparathyroidism, accounting for approximately 80%-90% of all cases. 1 Definitive treatment requires surgical excision, and preoperative localization with imaging is commonly used to decrease the size of surgical incisions and complication rates. 2 Imaging has been increasingly used for preoperative detection of parathyroid adenomas. While sonography and technetium Tc99m sestamibi scintigraphy have often been used as first-line imaging to localize PTA, these tests are often inconclusive. This situation has led to the development of multiphasic CT (4D CT), which identifies PTAs through their hypervascular perfusion pattern compared with lymph nodes and the thyroid gland. 4D CT has shown superior accuracy compared with scintigraphy, 3 though the radiation dose remains as high as 5.56 -10.4 mSv. [4] [5] [6] MR imaging is an attractive alternative to both scintigraphy and 4D CT due to the lack of radiation and has been used for the evaluation of PTAs with some success, [7] [8] [9] though not with the same effectiveness as 4D CT. Traditional technical limitations to localizing PTAs with MR imaging have recently been addressed with modern MR imaging technology. These include limited spatial and temporal resolution for multiphase dynamic contrast-enhanced MR imaging over a large FOV required for parathyroid imaging. This limitation can be addressed by the use of fast imaging tools such as time-resolved imaging with stochastic trajectories (TWIST) 10 and improved parallel imaging techniques such as controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA).
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The second limitation is inhomogeneity of fat suppression in the neck required for detection of small parathyroid adenomas. The Dixon fat-suppression technique 12 can dramatically improve this shortcoming. 13 In this study by using a modified dynamic contrast-enhanced sequence with incorporation of a TWIST-CAIPIRINHA combination and the Dixon fat saturation technique, we sought to describe MR perfusion characteristics of PTAs in a cohort of patients with pathology-proved PTA. We hypothesized that MR perfusion biomarkers can differentiate PTA from PTA mimics, such as subjacent thyroid gland and cervical lymph nodes.
MATERIALS AND METHODS
Informed consent was waived by the institutional review board for this retrospective single-institution study. Inclusion criteria were the following: 1) a patient with a known single PTA (confirmed by surgical pathology); and 2) preoperative dynamic 4D contrast-enhanced MR imaging available. Preoperative serum Ca 2ϩ and parathyroid hormone levels were also documented for each patient.
Imaging Protocol
All patients underwent MR imaging on a 3T Skyra MR imaging system (Siemens, Erlangen, Germany). A combination of 12-element head and neck coil was used for radiofrequency signal reception. Dynamic 4D contrast-enhanced MR imaging was performed by using a 3D volumetric interpolated examination sequence with the following parameters: TR ϭ 4.06 ms, first TE ϭ 1.31 ms, second TE ϭ 2.54 ms, flip angle ϭ 9°, matrix ϭ 160 mm, FOV ϭ 200 mm, 60 sections ϫ 2 mm thick. To improve inhomogeneity of fat suppression in the neck, we used the Dixon fatsuppression technique as described in prior reports. 12, 13 The TWIST view-sharing and Dixon fat/water separation were merged into 1 pulse sequence. 14 Bipolar readout gradients were used to produce 2 partial echoes at the first in-phase (TE ϭ 1.31 ms) and the second opposed-phase (TE ϭ 2.54 ms). Bipolar gradients allowed a shorter TR and less echo asymmetry. Integration of TWIST as an echo-sharing technique with a sampling density of 33% resulted in ϫ2 acceleration. In addition, CAIPIRINHA with an acceleration factor of 4 was incorporated as a parallelacquisition technique. This combination resulted in a net acceleration of 8, which was used to acquire a 3D dataset with a voxel size of 1.3 ϫ 1.3 ϫ 2 mm 3 and a temporal resolution of 6 seconds over a craniocaudal coverage of 120 mm, spanning the inferior mandibular rim to the carina. Twenty-four temporal frames were obtained during 140 seconds of acquisition time, 4 before contrast injection to establish a baseline. A total of 0.1 mmol/kg of gadolinium was injected at 4 mL/s.
Image Analysis
The perfusion datasets were processed by using commercially available US Food and Drug Administration-approved software (Olea Sphere; Olea Medical SAS, La Ciotat, France). Motion correction was implemented automatically by the software. Signalto-concentration conversion was performed [C(t) ϭ S(t) Ϫ S0], with S0 being the baseline signal. The arterial input function was selected automatically to deconvolute the concentration-time curve, assuming a multicompartmental model. 15 The concentration-time curve was then reconstructed from this analysis to obtain a noise-free signal.
Multiparametric quantitative perfusion parameters, including peak enhancement, time-to-peak (TTP), wash-in, and washout, were then computed from the reconvolved concentration-time curve. The wash-in and washout were defined by the initial upslope and downslope of the concentration-time curve, respectively. The definition of these parameters and how they are calculated from the concentration time curves are shown in Fig 1. Image coregistration was performed by using a 6-df transformation and a mutual-information cost function. This was followed by visual inspection to ensure adequate alignment. PTAs were identified by a fellowship-trained neuroradiologist in conjunction with the endocrine surgeon who performed all the surgeries. Using coregistered images, we placed ROIs over the known PTA, thyroid gland, and cervical lymph node (jugulodigastric station). Using the same ROIs, we also calculated the percentage of internal fat content of each PTA on precontrast T1 images before and after Dixon fat saturation.
Statistical Analysis
Statistical analysis was performed by using MedCalc for Windows, Version 14.12.0 (MedCalc Software, Mariakerke, Belgium). The semiquantitative data, including the peak enhancement, TTP, wash-in, and washout values of the PTA, thyroid gland, and cervical lymph node were plotted as mean and SD and tested for statistical significance by using a repeated-measures ANOVA with protected least-squares-difference post hoc tests. Logistic regression analysis was performed to identify the contribution of each perfusion parameter to the model. Receiver operating characteristic (ROC) analysis was performed to ascertain the optimal parameters and threshold for determination of PTA versus cervical lymph node and thyroid gland.
We calculated optimal thresholds for each ROC curve to maximize both sensitivity and specificity using the Youden statistic. Subsequently, an ROC curve for the combination of parameters was calculated, extrapolating from the maximum-likelihoodestimation model of combining classifiers. 16 The area under the curve was calculated for the ROC curve of each individual classifier and for the combined ROC curves. Correlation coefficients of perfusion parameters in PTA were calculated against the internal fat content of the PTA with 95% confidence intervals. The significance level was defined as P Ͻ .05.
RESULTS
Thirty patients (20 women, 10 men) with a mean age of 60 years (range, 27-79 years) were included. The preoperative serum Ca 2ϩ ranged from 9.9 to 12 mg/dL (mean, 10.92 mg/dL; interquartile range, 10.6 -11.2 mg/dL). The preoperative serum parathyroid hormone ranged from 52 to 246 pg/mL (mean, 115.3 pg/mL; interquartile range, 78 -147 pg/mL). The percentage of fat content of PTAs ranged from 7.2% to 71% (mean, 38.7%; interquartile range, 21.3%-59.5%). Patient demographic data and the size, weight, and location of parathyroid adenomas are listed in the On-line Table. Despite using motion correction, we found that in 7 patients (23%), 1-2 temporal frames were affected by motion artifacts. These frames were excluded from perfusion analysis. The mean Ϯ SD of MR perfusion parameters for PTA, thyroid gland, and cervical lymph node and the corresponding P values by using ANOVA analysis are summarized in Table 1 .
PTA versus Cervical Lymph Node
Three perfusion parameters, including TTP, wash-in, and washout, were significantly different between PTAs and cervical lymph nodes (Table 1) . PTAs showed significantly faster arterial enhancement with a mean TTP enhancement of 29 seconds earlier than that in lymph nodes (P Ͻ .001). PTAs also showed significantly higher (P Ͻ .001) wash-in and higher (P Ͻ .001) washout values in comparison with lymph nodes (Fig 2) . The peak enhancement was not significantly different between PTAs and cervical lymph nodes (P ϭ .38).
ROC curve analyses for differentiation of PTAs versus cervical lymph nodes and PTAs versus thyroid glands are shown in Fig 3. Optimal threshold values, area under the curve (AUC), and corresponding sensitivity and specificity for each perfusion parameter for the differentiation of PTA versus lymph node are summarized in Table 2 . With multiparametric MR perfusion analysis, a combination of TTP (threshold of Ͻ40 seconds), wash-in (threshold of Ͼ6.3), and washout (threshold of Ͼ0.62) improved the diagnostic power, resulting in an AUC of 0.96 with sensitivity/specificity of 88%/90% for differentiating PTAs (Fig 3) .
PTA versus Thyroid Gland
All 4 perfusion parameters were significantly different between PTAs and thyroid glands (Table 1) . Again PTAs showed significantly faster arterial enhancement with a mean TTP enhancement difference of 13 seconds earlier than that in thyroid glands (P ϭ .001). There was significantly higher peak enhancement (P Ͻ .001), wash-in (P Ͻ .001), and washout (P ϭ .016) in PTAs compared with thyroid glands (Fig 4) .
Optimal threshold values, AUC, and corresponding sensitivity and specificity for each perfusion parameter for the differentiation of PTA versus thyroid gland are summarized in Table 2 . The best sensitivity (86%) to differentiate PTA from thyroid gland was obtained by using the TTP value at a threshold of Ͼ37 seconds. Wash-in showed the highest specificity (90%) for differentiating PTA versus thyroid gland at a threshold value of Ͼ5.27. With multiparametric MR perfusion analysis, a combination of TTP (threshold of Ͼ30 seconds), wash-in (threshold of Ͼ5.86), and washout (threshold of Ͼ0.67) improved the diagnostic power resulting in an AUC of 0.96 with sensitivity/specificity of 91%/95% (Fig 3) . Logistic regression analysis indicated significant contribution from TTP (P ϭ .02; 95% CI, 0.88-.99), wash-in (P ϭ .03; 95% CI, 1.04 -3.06), and washout (P ϭ .008; 95% CI, 3.28 -37.15) for the differentiation of PTA from thyroid and cervical lymph nodes. There was no contribution from peak enhancement to differentiate PTA from thyroid and cervical lymph nodes (P ϭ .56; 95% CI, 0.98 -1.00).
Correlation analysis between the percentage of internal fat content and multiparametric perfusion values of PTAs showed only a significant (P ϭ .019) negative correlation (r ϭ Ϫ0.632) with washout values of PTAs. The correlation coefficients between the percentage of internal fat content of PTAs with peak enhancement, time-to-peak, and wash-in values were 0.150, 0.004, and Ϫ0.007, respectively.
DISCUSSION
In this study by using a modified MR imaging sequence with incorporation of fast imaging tools, for the first time, we describe MR perfusion characteristics of PTAs. We performed a multiparametric quantitative analysis and showed significant differences between perfusion biomarkers in PTAs versus cervical lymph nodes and thyroid gland. We note 3 findings:
First, the described MR imaging technique has significantly improved the traditional drawbacks of MR imaging, including limited spatial and temporal resolution. Using a modified MR image that incorporates fast imaging tools such as TWIST 10 and CAIPIRINHA 11 has allowed acquisition of multiphase contrastenhanced MR imaging with high spatial (1.3 ϫ 1.3 ϫ 2 mm ) and temporal (6 seconds) resolution.
Fast image acquisition and high spatial resolution have long been major advantages of CT; hence, significant attention has been given to 4D CT for the detection of PTAs. However, the main disadvantage of CT that can be addressed by the described MR imaging technique is radiation.
There is significant ongoing discussion in the literature as to which 4D CT protocol has a better diagnostic accuracy, whether a noncontrast scan is required, and how many postcontrast phases are required for optimal results without the added and unnecessary radiation dose. This discussion is beyond the scope of this article; however, effective radiation doses ranging from 5.56 to 10.4 mSv [4] [5] [6] have been reported, depending on the acquisition scheme used. Our second finding is that the described MR perfusion technique can successfully exploit the hypervascular nature of PTAs, a feature that can be used to differentiate them from PTA candidates such as subjacent cervical lymph node and thyroid tissue. The hypervascular nature of PTAs was shown in the 1970s by the use of arterial conventional angiography, demonstrating arterial blush as an indication of PTA against normal thyroid and parathyroid glands. 17, 18 Similar principles have been applied to dynamic contrast-enhanced CT and can be applied to MR imaging as shown in our results for the detection of PTAs.
Because continuous CT acquisition during the entire dynamic course of contrast through the parathyroid glands is restricted due to radiation concerns, 4D CT provides only snapshots of contrast dynamics at certain time points (depending on the number of acquisitions). There is no consensus on the number and timeinterval between CT acquisitions for an optimal 4D CT.
Therefore investigators have tried to identify acquisition schemes by using a combination of unenhanced and multiple postcontrast phases including 2 [25] [26] [27] with the time interval ranging from 30 to 90 seconds, each with strengths and limitations.
Compared with CT, the unique ability of MR imaging to sample many points on the contrast-versus-time curve allowed us to obtain perfusion characteristics such as TTP, peak-enhancement, wash-in, and washout. In our study, TTP and wash-in, 2 characteristics of arterial enhancement, were significantly higher in PTAs, indicative of their hypervascular nature in comparison with cervical lymph nodes and thyroid tissue. PTAs showed significant early arterial enhancement with a mean TTP of 13 and 29 seconds earlier than thyroid tissue and normal cervical lymph nodes, respectively. Logistic regression analysis indicated significant contribution from TTP, wash-in, and washout for the differentiation of PTA from thyroid and cervical lymph nodes but not from peak enhancement.
In addition, we showed the added value of multiparametric quantitative perfusion analysis to improve diagnostic accuracy over a single perfusion classifier to differentiate PTA among PTA candidates such as subjacent thyroid gland and cervical lymph nodes. Using multiparametric MR perfusion and combined ROC analysis, we found that the best overall model to distinguish PTA from cervical lymph node or subjacent thyroid tissue consisted of a combination of TTP, wash-in, and washout, yielding an AUC of 0.96, superior to any individual or combination of other classifiers.
Finally, we found a significant (P ϭ .019) negative correlation (r ϭ Ϫ0.632) between fat content percentage and washout values of PTAs. The clinical significance of this observation is rather unclear at this point. We assume that while TTP and wash-in are indicators of hypervascularity, the washout may be a reflection of the cellular content of PTAs. In other words, there is delayed clearance and contrast washout in lipid-rich adenomas with less cellularity. This finding should be interpreted with caution and within the 2-minute imaging window used in our study because some of these adenomas may further washout later, outside our imaging window.
This study has several limitations, including a relatively small sample size drawn from a single institution, possibly introducing a sample bias. In addition, inclusion of patients with known PTAs can further introduce selection bias. Another limitation is the retrospective nature of the study, possibly introducing unknown bias. The diagnostic accuracy of this MR imaging technique for the localization of PTA should be evaluated prospectively in a larger cohort. The last limitation is the insufficient availability and technical demands due to the 3T MR imaging scanners and mul- ticoil technology required for parallel imaging and the echo-sharing technique. Although all of these technologies are now commercially available, broad accessibility across imaging centers is still limited.
CONCLUSIONS
Dynamic 4D contrast-enhanced MR imaging can be obtained and used to exploit the hypervascular nature of PTAs. Multiparametric MR perfusion can distinguish PTAs from subjacent thyroid tissue or lymph nodes with a diagnostic accuracy of 96%.
